Elevance Health (ELV) Equity Average (2009 - 2026)

Elevance Health (ELV) has 18 years of Equity Average data on file, last reported at $43.9 billion in Q1 2026.

• Quarterly Equity Average rose 4.45% year-over-year to $43.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.9 billion (up 4.45% YoY) and the FY2025 annual result came in at $42.7 billion, up 5.54% from the prior year.
• Equity Average was little changed at $43.9 billion in Q1 2026 per ELV's latest filing, from $44.0 billion in the prior quarter.
• Across five years, Equity Average topped out at $44.0 billion in Q4 2025 and bottomed at $36.0 billion in Q3 2022.
• The 5-year median for Equity Average is $40.1 billion (2024), against an average of $40.0 billion.
• The widest annual swing landed in 2022, when Equity Average increased 0.61%; it then increased 12.13% in 2024.
• Tracing ELV's Equity Average over 5 years: stood at $36.2 billion in 2022, then grew by 7.68% to $39.0 billion in 2023, then gained by 9.44% to $42.7 billion in 2024, then increased by 3.12% to $44.0 billion in 2025, then slipped by 0.2% to $43.9 billion in 2026.
• Per Business Quant, the three latest ELV Equity Average figures stand at $43.9 billion (Q1 2026), $44.0 billion (Q4 2025), and $44.0 billion (Q3 2025).

Peer Comparison